Literature DB >> 11058632

Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy.

A de Vries1, J Griebel, C Kremser, W Judmaier, T Gneiting, P Debbage, T Kremser, K P Pfeiffer, W Buchberger, P Lukas.   

Abstract

PURPOSE: To measure microcirculatory changes during chemoirradiation and to correlate perfusion index (PI) values with therapy outcome.
MATERIALS AND METHODS: Perfusion data in 11 patients with cT3 (clinical staging, tumor invaded the perirectal tissue) rectal carcinoma who underwent preoperative chemoirradiation were analyzed. Perfusion data were acquired by using a T1 mapping sequence with a whole-body magnetic resonance (MR) imager. After contrast medium was intravenously infused at a constant rate, concentration-and-time curves were evaluated for arterial blood and tumor. All patients underwent MR imaging before and at constant intervals during chemoirradiation. Clinical stages before therapy were compared with surgical stages after therapy.
RESULTS: Spatial and temporal resolution on dynamic T1 maps were sufficient to reveal changes in contrast medium accumulation in the tumor. Comparison of PI values and radiation dose showed a significant increase in the 1st (P: =.003) and 2nd weeks (P: =.01) of treatment; values subsequently returned to pretreatment levels or showed a renewed increase. High initial PI values correlated with greater lymph node downstaging (P: =.042).
CONCLUSION: Dynamic T1 mapping provides a suitable tool for monitoring tumor microcirculation during chemoirradiation and offers the potential for individual optimization of therapeutic procedures. Furthermore, these results indicate that the PI map may serve as a prognostic factor.

Entities:  

Mesh:

Year:  2000        PMID: 11058632     DOI: 10.1148/radiology.217.2.r00nv02385

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.

Authors:  Ewelina Kluza; Esther D Rozeboom; Monique Maas; Milou Martens; Doenja M J Lambregts; Jos Slenter; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

Review 2.  Imaging tumour angiogenesis.

Authors:  Tony Jeswani; Anwar R Padhani
Journal:  Cancer Imaging       Date:  2005-12-01       Impact factor: 3.909

Review 3.  Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion.

Authors:  Yaron Gordon; Sasan Partovi; Matthias Müller-Eschner; Erick Amarteifio; Tobias Bäuerle; Marc-André Weber; Hans-Ulrich Kauczor; Fabian Rengier
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

4.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

5.  Perfusion CT in solid body-tumours. Part II: Clinical applications and future development.

Authors:  M Bellomi; S Viotti; L Preda; G D'Andrea; L Bonello; G Petralia
Journal:  Radiol Med       Date:  2010-03-09       Impact factor: 3.469

6.  Phase- and size-adjusted CT cut-off for differentiating neoplastic lesions from normal colon in contrast-enhanced CT colonography.

Authors:  W Luboldt; M Kroll; A Wetter; T L Toussaint; N Hoepffner; K Holzer; A Kluge; T J Vogl
Journal:  Eur Radiol       Date:  2004-09-23       Impact factor: 5.315

7.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

8.  Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model.

Authors:  Ho Yun Lee; Namkug Kim; Jin Mo Goo; Eui Kyu Chie; Hye Jong Song
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

9.  Prognostic aspects of DCE-MRI in recurrent rectal cancer.

Authors:  M J Gollub; K Cao; D H Gultekin; D Kuk; M Gonen; M Sohn; L H Schwartz; M R Weiser; L K Temple; G M Nash; J G Guillem; M Wang; J Garcia-Aguilar; K Goodman; P B Paty
Journal:  Eur Radiol       Date:  2013-08-27       Impact factor: 5.315

10.  Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.

Authors:  Esme J Hill; Corran Roberts; Jamie M Franklin; Monica Enescu; Nicholas West; Thomas P MacGregor; Kwun-Ye Chu; Lucy Boyle; Claire Blesing; Lai-Mun Wang; Somnath Mukherjee; Ewan M Anderson; Gina Brown; Susan Dutton; Sharon B Love; Julia A Schnabel; Phil Quirke; Ruth Muschel; William G McKenna; Michael Partridge; Ricky A Sharma
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.